Assembly Biosciences (ASMB) Other Operating Expenses (2016 - 2023)

Assembly Biosciences' Other Operating Expenses history runs 6 years deep, the most recent figure standing at -$75.2 million for Q4 2023.

• In Q4 2023, Other Operating Expenses changed N/A year-over-year to -$75.2 million; the TTM figure through Sep 2024 stood at -$75.2 million (changed N/A YoY), while the FY2023 annual figure was -$75.2 million, changed N/A from the prior year.
• Other Operating Expenses was -$75.2 million for Q4 2023 at Assembly Biosciences, down from $41.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $41.6 million in Q4 2021 to a low of -$75.2 million in Q4 2023.
• Historically, Other Operating Expenses has averaged -$8.4 million across 3 years, with a median of $2500.0 in 2019.
• Biggest YoY gain for Other Operating Expenses was 104.35% in 2019; the steepest drop was 103.15% in 2019.
• A 3-year view of Other Operating Expenses shows it stood at $4000.0 in 2019, then soared by 1040850.0% to $41.6 million in 2021, then tumbled by 280.67% to -$75.2 million in 2023.
• The last three Other Operating Expenses figures came in at -$75.2 million (Q4 2023), $41.6 million (Q4 2021), and $4000.0 (Q2 2019), per Business Quant data.